NCT01863433View on ClinicalTrials.gov

A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Influenza, Human
Interventions
BIOLOGICAL

Trivalent Influenza Vaccine

Trial Locations (1)

NW10 7EW

Study Site, London

All Listed Sponsors
lead

Seqirus

INDUSTRY

NCT01863433 - A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers | Biotech Hunter | Biotech Hunter